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Interval-value based Particle Swarm Optimiza-
tion classiﬁcationMicroarray technology allows simultaneousmeasurement of the expression levels of thousands of geneswithin a
biological tissue sample. The fundamental power ofmicroarrays lieswithin the ability to conduct parallel surveys
of gene expression usingmicroarray data. The classiﬁcation of tissue samples based on gene expression data is an
important problem inmedical diagnosis of diseases such as cancer. In gene expression data, the number of genes
is usually very high compared to the number of data samples. Thus the difﬁculty that lies with data are of high
dimensionality and the sample size is small. This research work addresses the problem by classifying resultant
dataset using the existing algorithms such as Support VectorMachine (SVM), K-nearest neighbor (KNN), Interval
Valued Classiﬁcation (IVC) and the improvised Interval Value based Particle Swarm Optimization (IVPSO) algo-
rithm. Thus the results show that the IVPSO algorithmoutperformed comparedwith other algorithms under sev-
eral performance evaluation functions.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cancer classiﬁcation using gene expression data usually relies on tra-
ditional supervised learning techniques, in which only labeled data
(i.e., data from a sample with clinical follow-up) can be exploited for
learning, while unlabeled data (i.e., data from a sample without clinical
follow-up) are disregarded [1]. Recent research in the area of cancer di-
agnosis suggests that unlabeled data in addition to the small number of
labeled data can produce signiﬁcant improvement in terms of accuracy
by using a technique called semi supervised learning. Indeed, semi su-
pervised learning has proved to be effective in solving different biolog-
ical problems including protein classiﬁcation, prediction of transcription
factor–gene interaction and gene-expression based cancer subtype dis-
covery. Microarray technology allows simultaneous measurement of
the expression levels of thousands of genes within a biological tissue
sample. An important application of gene expression is to classify sam-
ples according to their gene expression proﬁles, such as the diagnosis or
the classiﬁcation of different types or subtypes of cancer [2,3]. Different
classiﬁcation methods from statistical and machine learning have been
applied to the classiﬁcation of cancer. However, high dimensionality
and possibly a small number of noisy samples pose great challenges to
the existing methods. The main approach to this problem was based
on the existing algorithms to analyze gene expression data. Most ofa).
. This is an open access article underthe classiﬁers involve complex models containing numerous genes.
This has limited the interpretability of the classiﬁers and this lack of in-
terpretability hampers the acceptance of diagnostic tools. Classiﬁcation
models based on numerous genes can also be more difﬁcult to transfer
to other assay platforms, which may be more suitable for clinical appli-
cation. Several researchers pointed out that the classiﬁers might be de-
veloped to contain a small number of genes that provide classiﬁcation
accuracy comparable to that achieved bymodels that aremore complex
[4]. Moreover, some more complex algorithms based on numerous
genes for classiﬁcation often overﬁt the data [5].
Prior to classiﬁcation, a variety of gene selection strategies have been
used. The aim of gene selection is to select a small subset of genes from a
larger pool [6,7]. Gene selectionmethods are classiﬁed into three types:
(1) ﬁlter methods, (2) wrapper methods and (3) embedded methods.
Filter methods evaluate a subset of genes by looking at the intrinsic
characteristics of data with respect to class labels, while wrapper
methods evaluate the goodness of a gene subset by the accuracy of its
learning or classiﬁcation. Embedded methods are generally referred to
as algorithms, where gene selection is embedded in the construction
of the classiﬁer. In the gene selection process, an optimal feature subset
is always relative to a certain criterion. Every criterion measures the
discriminating ability of a gene or a subset of genes to distinguish differ-
ent class labels. To measure the gene–class relevance, different statisti-
cal and theoretical measures such as the t-test, entropy and mutual
information are typically used, and different metrics including the
Euclidean distance and correlation coefﬁcient are employed to calculate
the gene–gene redundancy [11,15].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 2.1
Performance comparison of existing and proposed methods for the leukemia dataset.
Algorithms/performance metrics TP rate FP rate Precision Accuracy
Support Vector Machine 70.97 28.61 43.75 69.01
K-Nearest Neighbor 80.27 22.2 90.0 71.28
Interval Valued Classiﬁcation 85.0 60.0 94.4 78.26
Particle Swarm Optimization 90.0 22.6 83.35 81.8
Interval Value based Particle
Swarm Optimization
100 0.0 90.0 96.88
Table 2.2
Performance comparison of existing and proposed methods for breast cancer dataset.
Algorithms/performance metrics TP rate FP rate Precision Accuracy
Support Vector Machine 71.26 29.45 70.75 71.87
K Nearest Neighbor 76.8 27.24 75.95 67.29
Interval Valued Classiﬁcation 80.1 25.24 75.66 74.86
Particle Swarm Optimization 82.8 20.86 79.87 84.63
Interval Value based Particle
Swarm Optimization
90.16 17.17 83.9 92.24
47D. Ramyachitra et al. / Genomics Data 5 (2015) 46–50In ﬁlters, the characteristics in the feature selection are uncorrelated
to those of the learning methods, therefore they have a better generali-
zation property [1]. The ﬁlters, wrapper and embedded are then ana-
lyzed to identify the most frequently appearing genes which would
correspond to the most predictive genes [2]. The Genetic Algorithm
combined with a Support Vector Machine classiﬁer is used for selecting
predictive genes and for ﬁnal gene selection and classiﬁcation. The anal-
ysis of gene expression data is to identify the sets of genes as classiﬁca-
tion or diagnosis platforms. Machine learning techniques, such as
artiﬁcial neural networks (ANNs), present a more ﬂexible ‘model-free’
approach for classiﬁcation and frequently yield good results [6]. The ad-
vantage of selecting a combination of genes with small redundancy, fa-
vors the selection of mutually uncorrelated genes. The selected set of
paired genes was used as a new feature set for the classiﬁcation.
In wrapper type methods, feature selection is “wrapped” around a
learningmethod and a feature is directly judged by the estimated accu-
racy of the learning method [11]. One can often obtain a set with a very
small number of non-redundant features, which gives high accuracy,
because the characteristics of the features match well with the charac-
teristics of the learning method [14]. Wrapper methods can use differ-
ent performance metrics and objective functions. And also the
wrapper methods select the “minimum” subset of features that pro-
vides the highest sensitivity. Embedded methods differ from other fea-
ture selection methods in the way that feature selection and learning
interact [14]. In contrast to ﬁlter andwrapper approaches, in embedded
methods the learning part and the feature selection part cannot be
separated — the structure of the class of functions under consideration
plays a crucial role [22].
2. Experiments
In this section, we evaluate the discriminative performance of our
selected gene set on different classiﬁers. We also compare the perfor-
mance of our proposed classiﬁcation method to a wide range of stan-
dard classiﬁers: Support Vector Machine (SVM), K Nearest Neighbor
(KNN), Particle Swarm Optimization (PSO) and Interval Value Classiﬁ-
cation (IVC). A set of experiments is conducted on the dataset by vary-
ing the number of genes selected to receive the highest classiﬁcation
accuracy.
2.1. Results on the leukemia dataset
To evaluate the performance of the proposed method in practice,
this research used the datasets containing gene expression proﬁles
from patients with acute lymphoblastic leukemia (ALL) and acute mye-
loblastic leukemia (AML). The leukemia dataset is collected from the
UCI Repository. In the leukemia dataset 72 samples are used for the
training set and 32 samples are used as the testing set. This dataset
have compared with the leukemia dataset that contains the ALL/AML
types. The ALL portion of the dataset is derived from two cell types, B-
cells and T-cells, while the AML part is split into two types as bonemar-
row (BM) samples and peripheral blood (PB). The correctly classiﬁed in-
stance for the leukemia dataset is 8.0 and incorrectly classiﬁed instance
is 1.0. The comparison has been done with proposed IVPSO and several
existing algorithm such as SVM, KNN, IVC. It has been found that the
proposed algorithm is better than the existing algorithm for classifying
the leukemia datasets. Table 2.1 shows the results for the leukemia
dataset and Fig. 2 shows the performance comparison of existing and
proposed algorithms for the leukemia dataset.
2.2. Results on the breast cancer dataset
To further test the performance of the proposed method the breast
cancer dataset is used for comparison, and it is collected from the UCI
Repository. Here the dataset consists of 69 samples from human cancer
cell lines. The breast cancer dataset spans nine classes and geneexpression levelsweremeasured for 769 genes. The prediction accuracy
of 74.86 is reported in reference using one-versus-the rest IVC with 150
selected genes. To test the proposed algorithm on an external dataset,
43 samples are used for the training dataset while 18 samples as the
testing dataset. Based on 150 genes selected and 12 genes selected by
PSO, the classiﬁcation accuracy report of all the compared algorithms
can be predicted. The correctly classiﬁed instance for the breast cancer
dataset is 7.2 and incorrectly classiﬁed instance is 2.8. Consistent with
the results on the breast cancer dataset in this experiment, the proposed
method also achieved the highest classiﬁcation accuracy. Thus Table 2.2
shows the results for the breast cancer dataset and Fig. 3 shows the
performance comparison of existing and proposed algorithms for the
breast cancer dataset.
2.3. Results on the lung cancer datasets
The performance of the proposed algorithm is calculated by using
the lung cancer dataset and it can be collected from the UCI Repository
which consists of 61 samples from human cancer cells. In the lung can-
cer dataset, the class and gene expression levels were measured for 462
genes. The prediction accuracy of IVC is 70.55 with 72 instances and 32
attributes. To test the proposed algorithm, a dataset of 43 samples was
used for the training dataset and 32 samples as the testing dataset.
The correctly classiﬁed instance for the lung cancer dataset is 7.2 and
the incorrectly classiﬁed instance is 2.8. Consistent with the results on
the lung cancer dataset in this experiment, the proposed method also
achieved the highest classiﬁcation accuracy. Thus Table 2.3 shows the
results for the lung cancer dataset and Fig. 4 shows the performance
comparison of existing and proposed algorithms for the lung cancer
dataset.
2.4. Results on blood cancer datasets
The performance of the proposed algorithm is also measured using
the blood cancer datasets and it can be collected from the NCBI data-
base. Blood cancer is an umbrella term for cancers that affect the bone
marrow, blood and lymphatic system. In this dataset a total of 399 in-
stances and 18 attributes were used. In this analysis, the data are
based on class distribution. In 339 instances, to test the proposed algo-
rithm a dataset of 48 samples were used for the training dataset and
36 samples as the testing dataset. The correctly classiﬁed instance is
7.8 and the incorrectly classiﬁed instances are 2.2. Consistent with the
results on the blood cancer dataset with this experiment, the proposed
method also achieved the highest classiﬁcation accuracy. Thus Table 2.4
shows the results for the blood cancer dataset and Fig. 5 shows the
Table 2.3
Performance comparison of existing and proposed methods for lung cancer dataset.
Algorithms/performance metrics TP rate FP rate Precision Accuracy
Support Vector Machine 71.30 28.4 71.4 70.55
K Nearest Neighbor 77.8 26.24 73.95 65.29
Interval Valued Classiﬁcation 79.19 24.08 76.67 79.03
Particle Swarm Optimization 83.27 21.03 79.83 80.02
Interval Value based Particle
Swarm Optimization
89.24 19.42 82.12 94.68
48 D. Ramyachitra et al. / Genomics Data 5 (2015) 46–50performance comparison of existing and proposed algorithms for the
blood cancer dataset.
2.5. Discussion
From the experimental results it is inferred that for the leukemia
dataset the proposed IVPSO algorithm performs 29.03% better than
the SVM algorithm, 19.73% better than the KNN algorithm, 15% better
than the IVC algorithm and 10% better than the PSO algorithm. For the
breast cancer dataset the proposed IVPSO algorithm performs 20.96%
better than the SVM algorithm, 14.82% better than the KNN algorithm,
11.16% better than the IVC algorithm and 8.16% better than the PSO al-
gorithm. And for the lung cancer dataset the proposed IVPSO algorithm
performs 20.11% better than the SVM algorithm, 12.82% better than the
KNN algorithm, 11.26% better than the IVC algorithm and 6.69% better
than the PSO algorithm. Finally, for the blood cancer dataset the pro-
posed IVPSO algorithmperforms 18.78% better than the SVM algorithm,
11.4% better than the KNN algorithm, 30.78% better than the IVC
algorithm, and 3.72% better than the PSO algorithm. Thus Fig. 1 shows
the comparison of accuracy for the leukemia, breast cancer, and lung
cancer and blood cancer datasets for the existing and proposed
algorithms.
(1) The accuracy of the classiﬁcation is highly dependent on the clas-
siﬁcation method. For instance, with the gene set selected by the
PSOmethod, the IVPSO classiﬁer has an accuracy of 96.88% on the
ALL–AML dataset, the average classiﬁcation accuracy.
IVPSO is 96.88% N SVM is 69.01% N KNN is 71.28% N IVC is 82.6%.
It is observed that proposed IVPSOmethod gets the best performance.
(2) The accuracy of the classiﬁcation is also highly dependent on the
selected gene set.When the genes are selected by the PSOmeth-
od, the SVM classiﬁer has an accuracy of 91.41% on the ALL–AML-
3 dataset. On the same dataset with the gene set selected by the
IVR method, the accuracy of SVM is 97.27%. This signiﬁcant dif-
ferential accuracy between the gene selection method of PSO
and IVC also occurs in the other classiﬁers.(3) It achieves better performance than any of the other classiﬁers. It
is conceivable that feature selection raises the accuracy since it
can reduce the number of insigniﬁcant dimensions, thereby
overcoming the curse of dimensionality. This appears to be the
case for the KNN and SVM classiﬁer methods. The accuracy of
KNN, Decision Tree and SVM is improved on the two datasets
with genes selected by the PSO method.100
ac
y(4) Remarkably, with the aid of feature selection, IVC achieves a
96.88% accuracy on the ALL–AML dataset and 92.24% accuracyTable 2.4
Performance comparison of existing and proposed methods for the blood cancer dataset.
Algorithms/performance metrics TP rate FP rate Precision Accuracy
Support Vector Machine 66 22.2 70 66.66
K Nearest Neighbor 72 25 72.3 72.82
Interval Valued Classiﬁcation 56.25 43.75 81.2 78.26
Particle Swarm Optimization 78.6 22.1 79.2 80.26
Interval Value based Particle
Swarm Optimization
81.26 18.19 83.6 90.86on the breast cancer dataset. For the SVM method, it is possible
to achieve very high accuracy onmost of themicroarray datasets
[24]. However, the best performance on the experimental
datasets does not outperform the IVPSO method.
From the results shown in Tables 2.1–2.4, it is inferred that the
IVPSO is the best method for sample classiﬁcation based on
gene expression. It achieves better performance than any of the
other classiﬁers. This appears to be the case for the SVM, KNN
and IVC classiﬁer methods. The accuracy of SVM, KNN and IVC
is improved on the four datasets with genes selected by the dif-
ferent methods. For the SVM method, it is possible to achieve
very high accuracy on most of the microarray datasets [24].
These four datasets have smaller sample sizes than those of the
other datasets, so onemay conclude thatmulticlass classiﬁcation
based on gene expression can be effectively solved when the
sample size is large. Although it is widely used in text categoriza-
tion in order to perform very well for tissue classiﬁcation based
on gene expression using the standard feature selection method
[24]. From the experimental results above, this research con-
cludes that the proposed approach is superior to other methods.
This may be due to the following advantages: interval-value
based particle swarm optimization, minimum redundancy of
the selected gene subset and simple classiﬁers.
The experimental results show that our proposed method has supe-
rior performance. Consecutively, in this work a new classiﬁcation algo-
rithm is proposed to classify the leukemia datasets. The tables and
graphs represent the comparison of performance measures for the
datasets such as leukemia, breast cancer, lung cancer and blood cancer.
We analyzed and compared the performance of existing classiﬁcation
algorithms such as SVM (Support Vector Machines), KNN (K Nearest
Neighbor), and Interval-valued Classiﬁcation (IVC), Particle Swarm Op-
timization (PSO) and the proposed PSO-IVC (Particle Swarm Optimiza-
tion–IVC). The performance is evaluated by using the parameters such
as accuracy, precision, true positive rate and false positive rate. From
the experimental results it is inferred that the proposed method
works better than the existing systems for classifying the datasets.
3. Gene selection and tissue sample classiﬁcation methods
The particle swarm optimization is a computational method which
optimizes a problem by continuously trying to enhance a candidate so-
lution with regard to a given measure of quality. In every iteration pro-
cess, each candidate solution is calculated by the objective function
being optimized, deciding theﬁtness of that solution. Every particle pre-
serves its position, composed of the candidate solution and its evaluated
ﬁtness, and its velocity.
3.1. Gene selection
Based on the Interval Value Based Particle Swarm Optimization, we
present a method to select the genes & tissue.
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Fig. 1. Comparison of accuracy on the leukemia, breast cancer, lung cancer and blood can-
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49D. Ramyachitra et al. / Genomics Data 5 (2015) 46–501. Initialize N number of particles in the swarm, each particle having a
position xi and velocity vi. Let pBest be the best known position of
particle i and gbest as the best known position of the entire swarm
2. Initialize the particle's position xi
3. For each particle i= 1, 2,… N
4. Calculate ﬁtness value for every particle
5. If ﬁtness value is better than the best ﬁtness value (pBest)
6. Set current value as the new pBest
7. Until a termination criterion is met
8. Select the particle with best ﬁtness value of all particles as the gbest
9. For every particle
10. //Calculation of particle velocity
11. vi t þ 1ð Þ ¼ wvi tð Þ þ c2r2 ~xı tð Þ−xi tð Þ½  þ c2r2 g tð Þ−xi tð Þ½  //Where,
the index of the particle is represented by i, vi tð Þ is the velocity of
particle i at time t, xi tð Þ is the position of particle i at time t; the pa-
rameters w, c1, and c2 are coefﬁcients
12. Update particle position
13. xi t þ 1ð Þ ¼ xi tð Þ þ vi t þ 1ð Þ
Until some stopping conditions are met.
4. Preliminaries
4.1. Microarray dataset
A microarray dataset is a gene expression data, in which each col-
umn represents a gene and each row represents a sample with a class
label. Let G = {g1, … …, gn} be a set of genes and U = {s1, ……, sm}
be a set of samples. The corresponding gene expression matrix can be
represented, as m is the number of samples and n is the number of
genes. The matrix X is composed of m row vectors i = 1,2,….,m. Each
vector in the gene expression matrix may be regarded as a point in n-
dimensional space, and each of the n columns consists of an m-
element expression vector for a single gene.
4.2. Particle Swarm Optimization
Particle Swarm Optimization was ﬁrst proposed by Kennedy and
Eberhart in 1995 [13]. PSO is a population based evolutionary algorithm
inspired by the social behavior of bird ﬂocking or ﬁsh schooling. In the0
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Fig. 3. Performance comparison of existing and proposed methods for the breast cancer
dataset.description of PSO, the swarm is made up of a certain number of parti-
cles (similar to population of individuals in EAs). At each iteration, all
the particles move in the problem space to ﬁnd the global optima.
Each particle has a current position vector and a velocity vector for
directing its movement.
The particle swarm optimization is a computational method which
optimizes a problem by continuously trying to enhance a candidate so-
lution with regard to a given measure of quality. In every iteration pro-
cess, each candidate solution is calculated by the objective function
being optimized, deciding theﬁtness of that solution. Every particle pre-
serves its position composed of the candidate solution and its evaluated
ﬁtness along with its velocity. Furthermore, it considers the best ﬁtness
value,whichhas been accomplished during the process of the algorithm
that which is referred to as the individual best ﬁtness, and the candidate
solution that achieved this ﬁtness, which is referred to as the individual
best position. At last, the PSO algorithmmaintains the best ﬁtness value
accomplished among all particles in the swarm, called the global best
ﬁtness, and the candidate solution that achieved this ﬁtness, called the
global best position or global best candidate solution.
vkþ1id ¼ w  vkid þ c1  rand1ðÞ  pkid−xkid
 
þ c2  rand2ðÞ  pkgd−xkidÞ 1
xkþ1id ¼ xkid þ vkþ1id 2
p!kþ1id ¼
x!kþ1i : Fitness x!
kþ1
i
 
N f itness p!kþ1i
 
p!ki : Fitness x!
kþ1
i
 
N f itness p!kþ1i
 
8<
: 3
p!kþ1i ¼ argmaxpi p!
kþ1
i : 4
PSO optimizes a problem by having solutions, here dubbed particles,
and moving these particles around in the search-space according to
simple mathematical formulae over the particle's position and velocity.
Each particle's movement is inﬂuenced by its local best known position
and is also guided toward the best known positions in the search-space,
which are updated as better positions are found by other particles. This
is expected tomove the swarm toward the best solutions. Although the
proposed method was originally designed for microarray data analysis,0
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Fig. 5. Performance comparison of existing and proposed methods for the blood cancer
dataset.
50 D. Ramyachitra et al. / Genomics Data 5 (2015) 46–50it can be applied to the data from the next generation sequencing
technologies.
p!kþ1i ¼ argmaxpi p!
kþ1
i x
kþ1
id ¼ xkid þ vkþ1id : 5
Eqs. (1) and (2) describe the velocity and position update of a given
particle i at a certain iteration k. Eq. (1) calculates a new velocity vi for
each particle (potential solution) based on its previous velocity, the
particle's location at which the best ﬁtness so far has been found p
Best i, and the population global (or local neighborhood, in the neigh-
borhood version of the algorithm) location at which the best ﬁtness so
far has been achieved. Individual and social weights are represented
by means of ‘1 and 2’ factors respectively. Finally, positions are random
numbers in range {0, 1}, and represent the inertia weight factor. Eq. (6)
updates each particle's position xi in solution Space.
4.3. Assessment metrics in the leukemia datasets.
Usually, the accuracy rate in Eq. (6) is themost frequently usedmea-
sure in assessment metrics. But in the framework of the leukemia
datasets, the accuracy is a proper measure, because it distinguishes be-
tween the numbers of correctly classiﬁed examples of different classes.
Acc ¼ TPþ TN
TPþ FNþ FPþ TN 6
TPrate ¼ TP
TPþ FN 7
FPrate ¼ FP
FPþ TN 8
Pre ¼ TP
TPþ FP 9
Truepositiverate TPRð Þ ¼ TP=P 10
P ¼ TPþ FNð Þ 11
where, P is Positive and TP is the True Positive.
5. Conclusion and future prospects
This research work proposed a combination method of Particle
SwarmOptimization and interval valued classiﬁcation based gene selec-
tion and sample classiﬁcation. This approach reduces the number of
genes selected and increases the classiﬁcation accuracy in terms of cor-
rectly and incorrectly classiﬁed instances. Many methods have been
proposed to solve this problem. But in this research work, performance
analysis has been done on various classiﬁers such as the SVM, KNN, PSO,
IVC and IVPSO. The proposed gene selection method can improve the
performance of the IVPSO classiﬁcation method to achieve an accuracyof 96.88%. Based on the classiﬁcation and comparison results, the pro-
posed algorithm performs better than other algorithms. The correctly
and incorrectly classiﬁed instances also have been detected. For all the
datasets the proposed algorithms perform better than the existing
methods in the case of numerical datasets. From the experimental anal-
ysis it is inferred that for all the datasets the proposed IVPSO algorithm
performs better than the existing classiﬁcation algorithms.
The proposed classiﬁcation technique can be easily extended to any
other applications different from the leukemia dataset problem. In fu-
ture, this method can be combined with any evolutionary algorithms
to get a new and more powerful classiﬁcation algorithm, and it can
also be extended along with different classiﬁcation techniques. In the
future it can also be solved on other datasets, and in the future it can
be extended tomodify the Interval Value based Particle Swarm Optimi-
zation algorithm to obtain more effective results by using different pa-
rameters. IVPSO classiﬁcation, for instance, can be well suited for gene
selection and different ﬁltering techniques. Since this task requires
rapid model updates with high level of accuracies, IVPSO can be a
good choice.
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